Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.
作者信息
Saijo Masayuki, Niikura Masahiro, Ikegami Tetsuro, Kurane Ichiro, Kurata Takeshi, Morikawa Shigeru
机构信息
Department of Virology 1, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan.
出版信息
Clin Vaccine Immunol. 2006 Apr;13(4):444-51. doi: 10.1128/CVI.13.4.444-451.2006.
Abstract
摘要
相似文献
1
Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.
Clin Vaccine Immunol. 2006 Apr;13(4):444-51. doi: 10.1128/CVI.13.4.444-451.2006.
2
Marburg and Ebola viruses.
Adv Virus Res. 1996;47:1-52. doi: 10.1016/s0065-3527(08)60733-2.
3
Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
J Pathol. 2015 Jan;235(2):153-74. doi: 10.1002/path.4456.
4
Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses.
Adv Exp Med Biol. 2006;582:35-44. doi: 10.1007/0-387-33026-7_4.
5
[Ebola virus and Marburg virus].
Nihon Rinsho. 2003 Mar;61 Suppl 3:544-9.
6
[Stabilization of peroxidase conjugates used in enzyme immunoassay systems to detect Ebola and Marburg virus antigens].
Vopr Virusol. 2010 Jan-Feb;55(1):45-8.
7
Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses.
Clin Vaccine Immunol. 2016 Aug 5;23(8):717-24. doi: 10.1128/CVI.00107-16. Print 2016 Aug.
8
Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.
J Clin Microbiol. 2001 Jan;39(1):1-7. doi: 10.1128/JCM.39.1.1-7.2001.
9
Emerging diseases. On the trail of Ebola and Marburg viruses.
Science. 2000 Nov 3;290(5493):923-5. doi: 10.1126/science.290.5493.923.
10
Laboratory diagnosis of Ebola and Marburg hemorrhagic fever.
Bull Soc Pathol Exot. 2005 Sep;98(3):205-9.
引用本文的文献
1
Marburg virus disease: Emerging threat, pathogenesis, and global public health strategies.
World J Virol. 2025 Jun 25;14(2):103576. doi: 10.5501/wjv.v14.i2.103576.
2
Marburg Virus Disease: A Narrative Review.
Health Sci Rep. 2025 May 6;8(5):e70669. doi: 10.1002/hsr2.70669. eCollection 2025 May.
3
Genomic Evolution and Phylodynamics of the Species (Marburg and Ravn Viruses) to Understand Viral Adaptation and Marburg Virus Disease's Transmission Dynamics.
Pathogens. 2024 Dec 14;13(12):1107. doi: 10.3390/pathogens13121107.
4
Evidence-Based Guidance for One Health Preparedness, Prevention, and Response Strategies to Marburg Virus Disease Outbreaks.
Diseases. 2024 Dec 2;12(12):309. doi: 10.3390/diseases12120309.
5
Recombinant proteins as promising antigens applied to the immunodiagnosis of Chagas disease: a scoping review.
Front Microbiol. 2024 Jul 30;15:1420226. doi: 10.3389/fmicb.2024.1420226. eCollection 2024.
6
Can Marburg virus be sexually transmitted?
Health Sci Rep. 2024 Aug 2;7(8):e2270. doi: 10.1002/hsr2.2270. eCollection 2024 Aug.
7
The mortality, modes of infection, diagnostic tests, and treatments of Marburg virus disease: A systematic review.
Health Sci Rep. 2023 Aug 31;6(9):e1545. doi: 10.1002/hsr2.1545. eCollection 2023 Sep.
8
Sagacious Perceptive on Marburg Virus Foregrounding the Recent Findings: A Critical Review.
Infect Disord Drug Targets. 2022;22(8):13-18. doi: 10.2174/1871526522666220510103618.
9
Zoonotic causes of febrile illness in malaria endemic countries: a systematic review.
Lancet Infect Dis. 2020 Feb;20(2):e27-e37. doi: 10.1016/S1473-3099(19)30629-2.
10
Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
BMC Infect Dis. 2018 Oct 3;18(1):498. doi: 10.1186/s12879-018-3409-x.
本文引用的文献
1
Fruit bats as reservoirs of Ebola virus.
Nature. 2005 Dec 1;438(7068):575-6. doi: 10.1038/438575a.
2
Marburg haemorrhagic fever, Angola.
Wkly Epidemiol Rec. 2005 May 6;80(18):158-9.
3
Outbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29, 2005.
MMWR Morb Mortal Wkly Rep. 2005 Apr 1;54(12):308-9.
4
Characterization of monoclonal antibodies to Marburg virus nucleoprotein (NP) that can be used for NP-capture enzyme-linked immunosorbent assay.
J Med Virol. 2005 May;76(1):111-8. doi: 10.1002/jmv.20332.
5
Exotic emerging viral diseases: progress and challenges.
Nat Med. 2004 Dec;10(12 Suppl):S110-21. doi: 10.1038/nm1142.
6
Rapid detection protocol for filoviruses.
J Clin Virol. 2004 May;30(1):94-9. doi: 10.1016/j.jcv.2003.09.004.
7
First international quality assurance study on the rapid detection of viral agents of bioterrorism.
J Clin Microbiol. 2004 Apr;42(4):1753-5. doi: 10.1128/JCM.42.4.1753-1755.2004.
8
Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome.
J Virol. 2004 Apr;78(8):4330-41. doi: 10.1128/jvi.78.8.4330-4341.2004.
9
Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.
Emerg Infect Dis. 2003 Dec;9(12):1531-7. doi: 10.3201/eid0912.030355.
10
Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus.
Med Microbiol Immunol. 2004 Nov;193(4):181-7. doi: 10.1007/s00430-003-0204-z. Epub 2003 Oct 31.
Zotero 插件